BRIEF-AstraZeneca to collaborate with Harvard Stem Cell Institute in diabetes – Reuters
|
BRIEF-AstraZeneca to collaborate with Harvard Stem Cell Institute in diabetes
Reuters March 25 (Reuters) – Astrazeneca Plc. * To collaborate with Harvard Stem Cell Institute in diabetesFurther company coverage: (Reporting By Ben Hirschler). FILED UNDER: Stocks · Markets · Healthcare … |
